194 related articles for article (PubMed ID: 27981892)
1. Phenethyl isothiocyanate suppresses the metastasis of ovarian cancer associated with the inhibition of CRM1-mediated nuclear export and mTOR-STAT3 pathway.
Shao WY; Yang YL; Yan H; Huang Q; Liu KJ; Zhang S
Cancer Biol Ther; 2017 Jan; 18(1):26-35. PubMed ID: 27981892
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.
Wang H; Wang L; Cao L; Zhang Q; Song Q; Meng Z; Wu X; Xu K
Mol Carcinog; 2018 Apr; 57(4):522-535. PubMed ID: 29278657
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.
Turner JG; Dawson J; Cubitt CL; Baz R; Sullivan DM
Semin Cancer Biol; 2014 Aug; 27():62-73. PubMed ID: 24631834
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer.
Wang Y; Wang Y; Xiang J; Ji F; Deng Y; Tang C; Yang S; Xi Q; Liu R; Di W
Cancer Lett; 2014 Feb; 343(1):6-13. PubMed ID: 24018641
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone.
Muqbil I; Aboukameel A; Elloul S; Carlson R; Senapedis W; Baloglu E; Kauffman M; Shacham S; Bhutani D; Zonder J; Azmi AS; Mohammad RM
Cancer Lett; 2016 Dec; 383(2):309-317. PubMed ID: 27693556
[TBL] [Abstract][Full Text] [Related]
6. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C
Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389
[TBL] [Abstract][Full Text] [Related]
7. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling.
Chen HJ; Lin CM; Lee CY; Shih NC; Amagaya S; Lin YC; Yang JS
Int J Oncol; 2013 Aug; 43(2):629-37. PubMed ID: 23754208
[TBL] [Abstract][Full Text] [Related]
8. Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.
Gong A; He M; Krishna Vanaja D; Yin P; Karnes RJ; Young CY
Mol Nutr Food Res; 2009 Jul; 53(7):878-86. PubMed ID: 19437484
[TBL] [Abstract][Full Text] [Related]
9. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells.
Bommareddy A; Hahm ER; Xiao D; Powolny AA; Fisher AL; Jiang Y; Singh SV
Cancer Res; 2009 Apr; 69(8):3704-12. PubMed ID: 19336571
[TBL] [Abstract][Full Text] [Related]
10. CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity.
Sakakibara K; Saito N; Sato T; Suzuki A; Hasegawa Y; Friedman JM; Kufe DW; Vonhoff DD; Iwami T; Kawabe T
Blood; 2011 Oct; 118(14):3922-31. PubMed ID: 21841164
[TBL] [Abstract][Full Text] [Related]
11. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.
Niu M; Chong Y; Han Y; Liu X
Cancer Biol Ther; 2015; 16(7):1110-8. PubMed ID: 25996664
[TBL] [Abstract][Full Text] [Related]
12. Nuclear export of proteins and drug resistance in cancer.
Turner JG; Dawson J; Sullivan DM
Biochem Pharmacol; 2012 Apr; 83(8):1021-32. PubMed ID: 22209898
[TBL] [Abstract][Full Text] [Related]
13. Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways.
Yang MD; Lai KC; Lai TY; Hsu SC; Kuo CL; Yu CS; Lin ML; Yang JS; Kuo HM; Wu SH; Chung JG
Anticancer Res; 2010 Jun; 30(6):2135-43. PubMed ID: 20651362
[TBL] [Abstract][Full Text] [Related]
14. CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA.
Kimura T; Hashimoto I; Nagase T; Fujisawa J
J Cell Sci; 2004 May; 117(Pt 11):2259-70. PubMed ID: 15126627
[TBL] [Abstract][Full Text] [Related]
15. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL
J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507
[TBL] [Abstract][Full Text] [Related]
16. SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway.
Chen M; Zeng J; Chen S; Li J; Wu H; Dong X; Lei Y; Zhi X; Yao L
Aging (Albany NY); 2020 Jun; 12(11):10896-10911. PubMed ID: 32516133
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of EGFR-AKT axis results in the suppression of ovarian tumors in vitro and in preclinical mouse model.
Loganathan S; Kandala PK; Gupta P; Srivastava SK
PLoS One; 2012; 7(8):e43577. PubMed ID: 22952709
[TBL] [Abstract][Full Text] [Related]
18. Dual Targeting of mTOR Activity with Torin2 Potentiates Anticancer Effects of Cisplatin in Epithelial Ovarian Cancer.
Hussain AR; Al-Romaizan M; Ahmed M; Thangavel S; Al-Dayel F; Beg S; Uddin S; Siraj AK; Al-Kuraya KS
Mol Med; 2015 May; 21(1):466-78. PubMed ID: 26023849
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection.
Lu C; Figueroa JA; Liu Z; Konala V; Aulakh A; Verma R; Cobos E; Chiriva-Internati M; Gao W
Curr Cancer Drug Targets; 2015; 15(7):575-92. PubMed ID: 26324128
[TBL] [Abstract][Full Text] [Related]
20. Phenethyl Isothiocyanate (PEITC) and Benzyl Isothiocyanate (BITC) Inhibit Human Melanoma A375.S2 Cell Migration and Invasion by Affecting MAPK Signaling Pathway
Ma YS; Hsiao YT; Lin JJ; Liao CL; Lin CC; Chung JG
Anticancer Res; 2017 Nov; 37(11):6223-6234. PubMed ID: 29061805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
